Fuchs Endothelial Corneal Dystrophy
Fuchs Endothelial Corneal Dystrophy
This patient-education article is written by the cornea service at Suraj Eye Institute, Nagpur.
What is Fuchs Endothelial Dystrophy?
Fuchs endothelial corneal dystrophy is a slowly progressive, usually inherited disease of the innermost layer of the cornea — the endothelium. The endothelium is a single layer of pump-cells that keep the cornea clear by pumping fluid out of it. In Fuchs dystrophy these cells gradually drop out and small wart-like excrescences called guttae appear on Descemet membrane. Once the cell count falls below the threshold needed to keep the cornea de-turgesced, the cornea swells and vision blurs.
Symptoms — What Patients Notice
Symptoms progress slowly over years and follow a typical pattern:
- Early — no symptoms; guttae are an incidental slit-lamp finding
- Intermediate — the cornea swells overnight, producing blurred vision on waking that clears through the morning
- Advanced — constant blurred vision, glare, and occasionally painful epithelial blisters (bullae)
How Fuchs Dystrophy is Diagnosed
Diagnosis is made at the slit-lamp by recognising the characteristic guttae (often described as a “beaten-bronze” appearance of the endothelium). Two non-contact investigations are central:
- Specular microscopy photographs the endothelial mosaic and measures the cell count (ECD); the decision to plan surgery is made together with the clinical picture — progressive vision loss, corneal swelling and whether a cataract is also present — rather than on the cell count alone.
- Anterior segment OCT and central corneal pachymetry detect corneal oedema and quantify thickness.
Treatment
Early Fuchs dystrophy needs no treatment beyond regular monitoring. Once corneal oedema produces functional visual symptoms, treatment options are:
- Hypertonic saline drops in the morning to draw fluid out of the cornea — useful while symptoms are mild.
- Endothelial keratoplasty — DSAEK or DMEK — selectively replaces only the diseased endothelial layer with healthy donor tissue. The choice between DSAEK and DMEK is made by the surgeon for each eye.
We use anterior-segment OCT for accurate staging and pachymetry, arrange specular microscopy through partner laboratories when an endothelial cell count is required, plan cataract surgery carefully in Fuchs eyes, and offer the full range of endothelial keratoplasty — DSAEK and DMEK — for advanced disease, supported by our partner eye bank for prompt donor tissue.
Frequently Asked Questions
